These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11174375)

  • 1. Correlation of Ki-67 expression in cutaneous primary melanoma with prognosis in a prospective study: different correlation according to thickness.
    Moretti S; Spallanzani A; Chiarugi A; Fabiani M; Pinzi C
    J Am Acad Dermatol; 2001 Feb; 44(2):188-92. PubMed ID: 11174375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear morphometry of MIB-1 positive and negative tumor cells in primary and metastatic malignant melanoma of the skin.
    Karbowniczek M; Chosia M; Domagała W
    Pol J Pathol; 1999; 50(4):235-41. PubMed ID: 10721263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.
    Hazan C; Melzer K; Panageas KS; Li E; Kamino H; Kopf A; Cordon-Cardo C; Osman I; Polsky D
    Cancer; 2002 Aug; 95(3):634-40. PubMed ID: 12209757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of Ki-67 expression in localized cutaneous malignant melanoma.
    Henrique R; Azevedo R; Bento MJ; Domingues JC; Silva C; Jerónimo C
    J Am Acad Dermatol; 2000 Dec; 43(6):991-1000. PubMed ID: 11100014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 expression in melanoma. A potential method of risk assessment for the patient with a positive sentinel node.
    Pearl RA; Pacifico MD; Richman PI; Stott DJ; Wilson GD; Grobbelaar AO
    J Exp Clin Cancer Res; 2007 Mar; 26(1):109-15. PubMed ID: 17550139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
    J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin A expression in superficial spreading malignant melanomas correlates with clinical outcome.
    Flørenes VA; Maelandsmo GM; Faye R; Nesland JM; Holm R
    J Pathol; 2001 Dec; 195(5):530-6. PubMed ID: 11745687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.
    Böni R; Doguoglu A; Burg G; Müller B; Dummer R
    J Am Acad Dermatol; 1996 Sep; 35(3 Pt 1):416-8. PubMed ID: 8784279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma.
    Thies A; Schachner M; Berger J; Moll I; Schulze HJ; Brunner G; Schumacher U
    J Pathol; 2004 Aug; 203(4):933-9. PubMed ID: 15258996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High proliferative activity may predict early metastasis of thin melanomas.
    Frahm SO; Schubert C; Parwaresch R; Rudolph P
    Hum Pathol; 2001 Dec; 32(12):1376-81. PubMed ID: 11774172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary melanoma of the skin and cutaneous melanomatous metastases: comparative histologic features and immunophenotypes.
    Guerriere-Kovach PM; Hunt EL; Patterson JW; Glembocki DJ; English JC; Wick MR
    Am J Clin Pathol; 2004 Jul; 122(1):70-7. PubMed ID: 15272532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrilysin (matrix metalloproteinase-7) in primary cutaneous and metastatic melanoma.
    Kawasaki K; Kawakami T; Watabe H; Itoh F; Mizoguchi M; Soma Y
    Br J Dermatol; 2007 Apr; 156(4):613-9. PubMed ID: 17493064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermatopathological indicators of poor melanoma prognosis are significantly inversely correlated with the expression of NM23 protein in primary cutaneous melanoma.
    Ferrari D; Lombardi M; Ricci R; Michiara M; Santini M; De Panfilis G
    J Cutan Pathol; 2007 Sep; 34(9):705-12. PubMed ID: 17696918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melanoma of the ear: prognostic factors and surgical strategies.
    Jahn V; Breuninger H; Garbe C; Moehrle M
    Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation of regression in primary melanoma with sentinel lymph node status.
    Kaur C; Thomas RJ; Desai N; Green MA; Lovell D; Powell BW; Cook MG
    J Clin Pathol; 2008 Mar; 61(3):297-300. PubMed ID: 17675538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of nuclear ING3 expression in human cutaneous melanoma.
    Wang Y; Dai DL; Martinka M; Li G
    Clin Cancer Res; 2007 Jul; 13(14):4111-6. PubMed ID: 17634537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.